Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate.
Singh
B N
BN
Department of Cardiology VA Medical Center, West Los Angeles, Los Angeles, CA 90073, USA.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001824:Body Constitution / Q000502:physiology; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006331:Heart Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality* / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008017:Life Expectancy; D008136:Longevity / Q000502:physiology*; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists